135th Annual Shattuck Lecture — GLP-1: Discovery and Impact on Health
Saturday, May 17, 2025, 12:45 to 1:45 p.m. EST
Live In-Person & Virtual
Joel F. Habener, MD
Joel F. Habener, MD, is Professor of Medicine (emeritus) at the Harvard Medical School, Honorary Scientist at the Massachusetts General Hospital, and a former Investigator with the Howard Hughes Medical Institute.
Dr. Habener is a discoverer of the insulinotropic hormone glucagon-like peptide-1, cyclic AMP response element binding protein, the islet duodenal homeodomain protein, and the existence of multipotent stem cells in the pancreas. Dr. Habener's discoveries contributed to the development of glucagon-like peptide-1, currently on the market as a treatment for diabetes.
Dr. Habener has been elected into a number of societies including the Association of American Physicians, National Academy of Sciences, and the National Academy of Inventors. He is the recipient of several awards, including more recently the Harrington Prize for Innovation in Medicine, Warren Alpert Foundation Prize, Harvard Medical School (2020), Canada Gairdner International Award (2021), VinFuture Foundation Prize for outstanding achievements in emerging fields (2023), Time100 List of 100 most influential people in the world (2024), Tang Prize in Biopharmaceutical Sciences (2024), Lasker-DeBakey Clinical Medical Research Award (2024), Princess of Asturias Award for Technical and Scientific Research (2024), Lifetime Achievement Award, Stanford Drug Discovery Symposium (2025), BBVA Foundation Frontiers of Knowledge Award in In Biology and Biomedicine (2025) and many others.
